Major driver for gamma polyglutamic acid market growth is high demand from the pharmaceutical industries. This is increasingly being used as a drug delivery system in cancer treatment. The research is underway for its application in a treatment of type I diabetes and its potential use in the production of an AIDS vaccine. Gamma polyglutamic acid vectors are useful for effective and safe gene therapy. It facilitates calcium absorption and hence, is useful in osteoporosis cases. It is also used as drug release carrier and hemostatic agent. Such factors are creating conductive environment for growth of the market.
Favorable growth of the pharmaceutical industry is projected to aid in growth of the gamma polyglutamic acid market. According to Hardman and Co., in 2016, global pharmaceuticals market was valued at US$ 816 billion. Rising demand for medicines and investments of companies in research and development to invent new drugs are expected to drive growth of the global demand of gamma polyglutamic acid.
Gamma polyglutamic acid is a natural product with longer moisture retention properties and maintains skin elasticity for more time. These products include Bio PGA, PGA Dual Moist, Twainmoist. Skin whitening, anti-wrinkle properties, and inhibition to melanin production are some of the characteristics of gamma polyglutamic acid fueling its demand for application in the cosmetics sector.